Senti Biosciences, Inc. (SNTI)
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer (CRC) cells, while sparing healthy cells in the body. The company was founded in 2016 and is based in South San Francisco, California.
$13.90M
Dr. Timothy K. Lu M.D., Ph.D.
89.00
South San Francisco, CA
-
-0.17
$-17.54
3.53
6.09
-2,573.97%
-0.28
0.17
7.17
5.77
-40.90%
-49.22%
Similar stocks (12)
Tyra Biosciences, Inc.
TYRA
Foghorn Therapeutics Inc.
FHTX
Fennec Pharmaceuticals Inc.
FENC
RAPT Therapeutics, Inc.
RAPT
ZIVO Bioscience, Inc.
ZIVO
Xilio Therapeutics, Inc.
XLO
SAB Biotherapeutics, Inc.
SABS
Monopar Therapeutics Inc.
MNPR
Cadrenal Therapeutics, Inc.
CVKD
Cingulate Inc.
CING
Lipella Pharmaceuticals Inc.
LIPO
Quoin Pharmaceuticals, Ltd.
QNRX
ETF Exposure (6)
ARK Genomic Revolution ETF
ARKG
0.04%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Tyra Biosciences, Inc.
TYRA
Foghorn Therapeutics Inc.
FHTX
Fennec Pharmaceuticals Inc.
FENC
RAPT Therapeutics, Inc.
RAPT
ZIVO Bioscience, Inc.
ZIVO
Xilio Therapeutics, Inc.
XLO
SAB Biotherapeutics, Inc.
SABS
Monopar Therapeutics Inc.
MNPR
Cadrenal Therapeutics, Inc.
CVKD
Cingulate Inc.
CING
Lipella Pharmaceuticals Inc.
LIPO
Quoin Pharmaceuticals, Ltd.
QNRX
ETF Exposure (6)
ARK Genomic Revolution ETF
ARKG
0.04%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%